4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-23-018141
Chief Financial Officer gave up 9,676 shares (to pay taxes)
- Chief Financial Officer acquired 40,667 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Foster Jonathan P. Chief Financial Officer | 2023-06-20 | Option exercise | +40,667 | 61,246 | D | ||
| Foster Jonathan P. Chief Financial Officer | 2023-06-20 | Shares withheld for taxes | −9,676 | $0.57 | $5,515 | 51,570 | D |
| Derivatives | |||||||
| Foster Jonathan P. Chief Financial Officer | 2023-06-20 | Option exercise · Restricted Stock Units | −40,667 | 680,938 | D | ||
Loading xslF345X04/rdgdoc.xml…